Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
OCULAR SCIENCES INC (OCLR) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/16/2004 8-K Quarterly results
11/09/2004 8-K Quarterly results
Docs: "OCULAR SCIENCES REPORTS THIRD QUARTER RESULTS"
10/18/2004 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment No. 1 to Agreement and Plan of Merger, by and among The Cooper Companies, Inc., TCC Acquisition Corp. and Ocular Sciences, Inc"
07/29/2004 8-K Other events, Financial statements and exhibits
Docs: "OCULAR SCIENCES REPORTS SECOND QUARTER RESULTS"
07/29/2004 8-K Other events, Financial statements and exhibits
Docs: "EXECUTION COPY AGREEMENT AND PLAN OF MERGER BY AND AMONG THE COOPER COMPANIES, INC. TCC ACQUISITION CORP. AND OCULAR SCIENCES, INC. DATED AS OF JULY 28, 2004",
"WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (C) IT MAKES SUCH WAIVERS VOLUNTARILY, AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL",
"THE COOPER COMPANIES TO ACQUIRE OCULAR SCIENCES"
05/06/2004 8-K Other events
05/04/2004 8-K Results of Operations and Financial Condition, Financial statements and exhibits
Docs: "OCULAR SCIENCES REPORTS CONTINUED GROWTH IN FIRST QUARTER 2004"
02/19/2004 8-K Results of Operations and Financial Condition, Financial statements and exhibits
Docs: "OCULAR SCIENCES REPORTS STRONG FOURTH QUARTER RESULTS"
10/29/2003 8-K Results of Operations and Financial Condition, Financial statements and exhibits
Docs: "OCULAR SCIENCES REPORTS SOLID THIRD QUARTER RESULTS - REVENUE UP 14%; INTERNATIONAL REVENUE GREW 24%; - E.P.S. OF $0.38; $0.50 PRIOR TO MANUFACTURING CONSOLIDATION EXPENSES - SIGNIFICANT SEQUENTIAL OPERATING MARGIN IMPROVEMENT - COMPANY GENERATES CASH FLOW FROM OPERATIONS OF MORE THAN $20 MILLION"
07/30/2003 8-K Results of Operations and Financial Condition, Regulation FD Disclosure
Docs: "OCULAR SCIENCES REPORTS CONTINUED PROGRESS IN SECOND QUARTER - REVENUE UP 16%; INTERNATIONAL REVENUE GREW 27% - E.P.S. OF $0.17; $0.34 PRIOR TO MANUFACTURING CONSOLIDATION EXPENSES - REVENUE & EARNINGS ARE ABOVE ESTIMATES"
05/08/2003 8-K Regulation FD Disclosure
Docs: "OCULAR SCIENCES REPORTS FIRST QUARTER RESULTS - REVENUE UP 16%; INTERNATIONAL REVENUE GREW 40%; ORGANIC GROWTH OF 10% - E.P.S. OF $0.25; $0.29 PRIOR TO MANUFACTURING CONSOLIDATION EXPENSES - COMPANY REAFFIRMS 2003 GUIDANCE"
08/14/2002 8-K Regulation FD Disclosure
02/26/2001 8-K Other events, Financial statements and exhibits
Docs: "OCULAR SCIENCES COMPLETES ACQUISITION OF ESSILOR CONTACT LENS OPERATIONS"
04/28/2000 8-K Other events
06/08/1999 8-K Other events

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy